We are live on ! Find out more
IA

Icon Advisers Portfolio holdings

AUM $433M
1-Year Est. Return 40.01%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
+40.01%
3 Year Est. Return
+86.89%
5 Year Est. Return
+109.98%
10 Year Est. Return
+379.02%
AUM
$1.48B
AUM Growth
-$32.7M
Cap. Flow
-$109M
Cap. Flow %
-7.37%
Top 10 Hldgs %
14.41%
Holding
481
New
65
Increased
93
Reduced
146
Closed
86

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$12M
2
PFE icon
Pfizer
PFE
+$9.4M
3
NFG icon
National Fuel Gas
NFG
+$8.62M
4
EW icon
Edwards Lifesciences
EW
+$8.02M
5
NWL icon
Newell Brands
NWL
+$7.17M

Top Sells

Rank Stock Value
1
PSX icon
Phillips 66
PSX
+$9.43M
2
SIVB
SVB Financial Group
SIVB
+$8.99M
3
ASH icon
Ashland
ASH
+$8.15M
4
MCK icon
McKesson
MCK
+$7.87M
5
BRS
Bristow Group, Inc.
BRS
+$6.92M

Sector Composition

Rank Sector Weight
1 Energy 22.88%
2 Healthcare 13.46%
3 Financials 12.73%
4 Consumer Discretionary 9.28%
5 Technology 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORA icon
301
Ormat Technologies
ORA
$6.11B
$799K 0.05%
+14,900
New +$724K
RDN icon
302
Radian Group
RDN
$5.14B
$793K 0.05%
44,100
+11,800
+37% +$177K
GE icon
303
GE Aerospace
GE
$367B
$790K 0.05%
+5,217
New +$758K
WSM icon
304
Williams-Sonoma
WSM
$26.7B
$789K 0.05%
32,600
AMPH icon
305
Amphastar Pharmaceuticals
AMPH
$825M
$774K 0.05%
+42,000
New +$817K
LGND icon
306
Ligand Pharmaceuticals
LGND
$6.02B
$770K 0.05%
12,143
BTI icon
307
British American Tobacco
BTI
$132B
$766K 0.05%
+13,600
New +$770K
ULTA icon
308
Ulta Beauty
ULTA
$20.4B
$765K 0.05%
3,000
-300
-9% -$74.9K
ISRG icon
309
Intuitive Surgical
ISRG
$121B
$761K 0.05%
+10,800
New +$794K
TAP icon
310
Molson Coors Class B
TAP
$7.68B
$749K 0.05%
7,700
+3,900
+103% +$398K
MNST icon
311
Monster Beverage
MNST
$91.4B
$732K 0.05%
33,000
UNP icon
312
Union Pacific
UNP
$183B
$705K 0.05%
6,800
-49,860
-88% -$4.9M
AYI icon
313
Acuity Brands
AYI
$9.88B
$693K 0.05%
+3,000
New +$728K
F icon
314
Ford
F
$57.3B
$691K 0.05%
57,000
-34,100
-37% -$414K
IP icon
315
International Paper
IP
$22.3B
$690K 0.05%
13,728
-65,578
-83% -$3.03M
SCG
316
DELISTED
Scana
SCG
$689K 0.05%
9,400
-6,300
-40% -$450K
MPWR icon
317
Monolithic Power Systems
MPWR
$65.5B
$688K 0.05%
8,400
-7,900
-48% -$634K
MDC
318
DELISTED
M.D.C. Holdings, Inc.
MDC
$687K 0.05%
+33,729
New +$629K
MON
319
DELISTED
Monsanto Co
MON
$663K 0.04%
6,300
AMG icon
320
Affiliated Managers Group
AMG
$9.46B
$654K 0.04%
4,500
CACC icon
321
Credit Acceptance
CACC
$6B
$653K 0.04%
+3,000
New +$582K
PDCO
322
DELISTED
Patterson Companies, Inc.
PDCO
$648K 0.04%
+15,800
New +$682K
FNGN
323
DELISTED
Financial Engines, Inc.
FNGN
$647K 0.04%
+17,600
New +$566K
CNS icon
324
Cohen & Steers
CNS
$4.18B
$642K 0.04%
+19,100
New +$698K
EL icon
325
Estee Lauder
EL
$29B
$627K 0.04%
8,200
-9,200
-53% -$748K

Similar funds

Icon Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, Icon Advisers held 481 positions worth $1.48B, down 2.2% from $1.51B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Icon Advisers withdrew a net $109M in Q4 2016, closing 86 positions and reducing 146 holdings. Its most notable exit was Phillips 66, an estimated $9.43M position sold in full.

By sector, the portfolio is most concentrated in Energy at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Icon Advisers opened a new position in Johnson & Johnson worth $12M.

  • Icon Advisers's largest Q4 2016 buy was Johnson & Johnson: 103,800 shares worth $12M.
  • Icon Advisers added most to Pfizer in Q4 2016, an estimated $9.4M increase.
  • Icon Advisers's biggest Q4 2016 reduction was SVB Financial Group, cutting an estimated $8.99M.
  • Icon Advisers fully exited Phillips 66 in Q4 2016, selling an estimated $9.43M.
  • Icon Advisers's ten largest holdings make up 14% of its $1.48B portfolio in Q4 2016.
  • Icon Advisers opened 65 new positions and closed 86 in Q4 2016.
  • Icon Advisers's portfolio value fell 2.2% quarter-over-quarter to $1.48B.

Based on Icon Advisers's 13F filing for Q4 2016, filed 1 Feb 2017.